Cellectar Biosciences (CLRB) PT Raised to $14 at Oppenheimer
Tweet Send to a Friend
(Updated - July 24, 2024 1:58 PM EDT)
Oppenheimer analyst Jeff Jones raised the price target on Cellectar Biosciences ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Jeff Jones raised the price target on Cellectar Biosciences ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
